7 Pulmonology Headlines – August 2025
Okay, I’ve reviewed the text you provided. Hear’s a summary of the key pulmonology updates from August 2025, according to the article:
Key Pulmonology Updates – August 2025:
Lung Cancer: Progress in early detection through low-dose CT scans and liquid biopsy biomarkers. Evolving treatment options are improving outcomes, but access and implementation remain challenges. Bronchiectasis: the FDA approved brensocatib for patients 12 and older. It’s the first therapy targeting neutrophil-driven inflammation and reduces exacerbation rates.
Recurrent Respiratory Papillomatosis: The FDA approved zopapogene imadenovec-drba (Papzimeos), the first immunotherapy for adults with this condition.
Sinusitis: Updates reinforce cautious antibiotic use, watchful waiting, and shared decision-making. Guidance is also provided for biologic therapies in chronic rhinosinusitis with nasal polyps.
* Pediatric Asthma: New predictive models using oral microbiome profiles, serum inflammatory mediators, and past attack history are improving accuracy in identifying children at risk of severe attacks.
In essence, August 2025 saw advancements in treatment options for several respiratory diseases, including the approval of new therapies for bronchiectasis and recurrent respiratory papillomatosis, as well as improvements in early detection and risk prediction for lung cancer and pediatric asthma, respectively.The article also highlights the importance of responsible antibiotic use in sinusitis management.